Skip to Content

Kreg Anderson Workshop

Kreg Anderson Workshop Prevention of 
Chemotherapy-induced Cardiotoxicity

November 15, 2013

Opening: Edward T. H. Yeh, M.D.

SESSION I: Cardiotoxicity of Chemotherapy: Four Different Perspectives
Moderator: Michael Ewer, M.D., J.D., M.P.H.

The Critical Role of Anthracyclines in the Treatment of Lymphoma
Alma Rodriguez, M.D., F.A.C.P.

Anthracycline in the Treatment of Breast Cancer
Sandra Swain, M.D.      

The Value of Protection from Adriamycin Cardiac Toxicity in the Management of Sarcoma
Robert Benjamin, M.D.

Cardioprotection Strategies during Cancer Treatments for Long-Term Prevention of Cardiotoxicity in Children with Cancer
Steven Lipshultz, M.D.

Question and Answer Session
Moderator: Michael Fisch, M.D., M.P.H.

SESSION II: Primary and Secondary Prevention of Chemotherapy-induced Cardiotoxicity
Moderator: Michael Fisch, M.D., M.P.H.

Primary Prevention
Edward T.H. Yeh, M.D.       

Controversy with Dexrazoxane
Michael Ewer, M.D., J.D., M.P.H.    

Secondary Prevention
Jean-Bernard Durand, M.D.      

Survivorship
Anecita Fadol, Ph.D., M.S.N.  

SESSION III: Round Table Discussion: All Speakers
Moderator:  Edward T.H. Yeh, M.D.

Join the Heart Mail List

Join the Heart Mail List to get email updates about our programs and events.
Please complete this form.

Important Publications

Vejpongsa, P and Yeh, ET.
Prevention of Anthracycline-Induced Cardiotoxicity: Challenges and Opportunities. J Am Coll Cardiol. 2014; 64(9):938-945.

View Publications


© 2014 The University of Texas MD Anderson Cancer Center